版本:
中国

BRIEF-Zosano Pharma appoints John Walker as interim CEO

May 9 Zosano Pharma Corp

* Zosano reports first quarter 2017 financial results and announces management changes

* Q1 loss per share $0.34

* Says John P. Walker appointed interim CEO

* Zosano Pharma Corp - John P. Walker named interim chief executive officer to replace Konstantinos Alataris who has resigned as CEO

* Zosano Pharma Corp - Georgia Erbez, chief business officer and interim chief financial officer, has assumed full responsibility for both functions Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐